| Megan Gaillard, | |
|
2664 S Harper Rd, Corinth, MS 38834-6723 | |
| (662) 287-4055 | |
| (662) 287-4114 |
| Full Name | Megan Gaillard |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 2664 S Harper Rd, Corinth, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114445426 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Megan Gaillard, 2664 S Harper Rd, Corinth, MS 38834-6723 Ph: (662) 287-4055 | Megan Gaillard, 2664 S Harper Rd, Corinth, MS 38834-6723 Ph: (662) 287-4055 |
News Archive
A two-year study conducted by researchers at George Mason University, INOVA Fairfax Hospital and the National Cancer Institute may open the door to new therapies for combating chronic diseases associated with obesity, a condition that affected more than 33 percent of American adults in 2005-06 according to the Centers for Disease Control and Prevention.
As the COVID-19 coronavirus pandemic grips the US, a new free app is helping to track the onset and progression of symptoms of millions across the nation. The app will help identify those at risk sooner, and help slow the outbreak of the disease.
An international team of physicists at Los Alamos National Laboratory has succeeded in using intense laser light to accelerate protons to energies never before achieved. Using this technique, scientists can now accelerate particles to extremely high velocities that would otherwise only be possible using large accelerator facilities. Physicists around the world are examining laser particle acceleration and laser produced radiation for potential future uses in cancer treatment.
Up to one million people in Cote d'Ivoire have fled escalating violence in the city of Abidjan, Melissa Fleming, a spokesperson for the U.N. High Commissioner for Refugees, said at a news briefing in Geneva on Friday, Reuters reports.
Genzyme Corporation announced today that the FDA has granted U.S. marketing approval for Lumizyme™ (alglucosidase alfa), produced at the 4000 liter (L) bioreactor scale at its manufacturing facility in Geel, Belgium. Lumizyme is the first treatment approved in the United States specifically to treat patients with late-onset Pompe disease.
› Verified 9 days ago
Ashley L Saulter, PCMHT, NCE Counselor Medicare: Not Enrolled in Medicare Practice Location: 311 South Cass Street, Corinth, MS 38834 Phone: 662-286-2152 Fax: 662-286-8095 | |
Thomas Wilson Harington, Counselor Medicare: Not Enrolled in Medicare Practice Location: 601 Foote St, Corinth, MS 38834 Phone: 662-287-4424 Fax: 662-287-2070 | |
Latoya Yvette Cobbs, PCCMP Counselor Medicare: Not Enrolled in Medicare Practice Location: 2664 S Harper Rd, Corinth, MS 38834 Phone: 662-287-4055 Fax: 662-287-4114 | |
Ida Pat Patterson, PCMHT Counselor Medicare: Not Enrolled in Medicare Practice Location: 601 Foote St, Corinth, MS 38834 Phone: 662-287-4424 Fax: 662-286-8095 | |
Tammy Robertson, CMHT Counselor Medicare: Not Enrolled in Medicare Practice Location: 104 New Hope Road, Corinth, MS 38834 Phone: 662-287-7199 Fax: 662-286-8095 | |
Ladonna Pybus, Counselor Medicare: Not Enrolled in Medicare Practice Location: 806 S Parkway St, Corinth, MS 38834 Phone: 662-536-6210 | |
Audrey Hector, Counselor Medicare: Not Enrolled in Medicare Practice Location: 601 Foote St, Corinth, MS 38834 Phone: 662-287-4424 Fax: 662-287-2070 |